Ascentage Pharma Group International (AAPG) Receivables - Net (2023 - 2025)
Historic Receivables - Net for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $10.9 million.
- Ascentage Pharma Group International's Receivables - Net changed N/A to $10.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.9 million, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2024, which is 4482.71% down from last year.
- As of Q2 2025, Ascentage Pharma Group International's Receivables - Net stood at $10.9 million.
- Ascentage Pharma Group International's Receivables - Net's 5-year high stood at $20.3 million during Q4 2023, with a 5-year trough of $10.9 million in Q2 2025.
- Moreover, its 3-year median value for Receivables - Net was $11.6 million (2024), whereas its average is $14.3 million.
- Within the past 5 years, the most significant YoY rise in Ascentage Pharma Group International's Receivables - Net was 4287.63% (2024), while the steepest drop was 4287.63% (2024).
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Receivables - Net stood at $20.3 million in 2023, then crashed by 42.88% to $11.6 million in 2024, then dropped by 5.49% to $10.9 million in 2025.
- Its last three reported values are $10.9 million in Q2 2025, $11.6 million for Q4 2024, and $20.3 million during Q4 2023.